1-8 of 8
E. Ricky Chan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PSMC2 Overexpression Promotes Synthetic Lethality Sensitizing Multiple Myeloma Cells to p97 Inhibition

James J Ignatz-Hoover, Pryianka Rana, John D'Cruz, E Ricky Chan, Ehsan Malek, James J. Driscoll, II
Journal: Blood
Blood (2024) 144 (Supplement 1): 3280.
https://doi.org/10.1182/blood-2024-211260
Published: 2024
Journal Articles

PSMC2 Overexpression Enhances Proteasome Activity, Mitigates ER Stress, and Correleates with Reduced Overall Survival in Multiple Myeloma

James J. Ignatz-Hoover, E Ricky Chan, Jack D'Cruz, Pryianka Rana, Ehsan Malek, James J. Driscoll, II
Journal: Blood
Blood (2023) 142 (Supplement 1): 6617.
https://doi.org/10.1182/blood-2023-190462
Published: 2023
Journal Articles

Proteasome Regulatory Atpases PSMC2 and PSMC6 Modulate Proteosome Inhibitor Sensitivity and Correlate with Survival in Multiple Myeloma

James Ignatz-Hoover, E Ricky Chan, Ehsan Malek, James J. Driscoll
Journal: Blood
Blood (2022) 140 (Supplement 1): 4305–4306.
https://doi.org/10.1182/blood-2022-170510
Published: 2022
Journal Articles

Whole-Exome Sequencing Identifies a Somatic Cell Mutation Signature That Predicts Relapse Risk and Survival Probability in Multiple Myeloma

Ehsan Malek, MD, E. Ricky Chan, PhD, Daniel Qu, Jane Reese, Robert Fox, Byung-Gyu Kim, PhD DVM, Paolo F Caimi, MD, Marcos de Lima, MD, James J. Driscoll, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-142791
Published: 2020
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results

Anjali S. Advani, MD, Brenda W. Cooper, MD, Valeria Visconte, PhD, Paul Elson, PhD, E. Ricky Chan, PhD, Jennifer Carew, PhD, Sudipto Mukherjee, MD PhD MPH, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Paolo Caimi, MD, Benjamin Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Jaime Fensterl, Allison Unger, Cassie Zimmerman, Christopher Goebel, Nita Hoxha, Caitlin Siebenaller, Jenna Thomas, Mary Lynn Rush, RN, Samjhana Bogati, RN, Eric Parsons, RN, Rachael Diligente, RN, Donna Kane, RN, MSN, Alek Nielsen, BS, Cassandra M. Hirsch, BS, Simone Edelheit, Alexander Miron, PhD, John Pink, PhD, Jaroslaw P. Maciejewski, PhD MD FACP, Matt Kalaycio, MD, Marcos De Lima, MD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 150.
https://doi.org/10.1182/blood.V130.Suppl_1.150.150
Published: 2017
Journal Articles

Premature Platelet Activation and Resistance to P2Y12 Inhibitors in Rasa3 Mutant Mice

Wolfgang Bergmeier, PhD, David S Paul, PhD, Lucia Stefanini, PhD, Raymond F. Robledo, PhD, E. Ricky Chan, PhD, Todd M Getz, PhD, Raymond Piatt, Yacine Boulaftali, PhD, Mark D Adams, Luanne L. Peters, PhD
Journal: Blood
Blood (2014) 124 (21): 91.
https://doi.org/10.1182/blood.V124.21.91.91
Published: 2014
Journal Articles

Positional Cloning of the Mouse Scat Mutation Reveals a Critical Role for RASA3, a Ras GTPase Activating Protein, in Vertebrate Erythropoiesis.

Luanne L. Peters, PhD, Steven L. Ciciotte, MS, E. Ricky Chan, Ph.D, Babette Gwynn, MS, Amy J. Lambert, BS, Eric L. Pierce, BS, Kathleen A. Soltis, BS, Mark D. Adams, PhD, Barry H. Paw, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 776.
https://doi.org/10.1182/blood.V114.22.776.776
Published: 2009
Journal Articles

Two Mouse Genetic Models of Thrombocytopenia.

E. Ricky Chan, Heather Lavender, Karrie Trevarthen, Peter Haviernik, Kevin D. Bunting, Mark D. Adams
Journal: Blood
Blood (2006) 108 (11): 1108.
https://doi.org/10.1182/blood.V108.11.1108.1108
Published: 2006